Verastem Oncology welcomes John H. Johnson to its Board of Directors

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Verastem, Inc. (Nasdaq: VSTM), a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer, today announced the appointment of John H. Johnson to its Board of Directors. Mr. Johnson will serve on the Compensation and Nominating and Governance Committees. Mr. Johnson's career ...

Verastem Oncology welcomes John H. Johnson to its Board of Directors

Verastem Oncology welcomes John H. Johnson to its Board of Directors

From:: Verastem Oncology welcomes John H. Johnson to its Board of Directors